About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Comparing Two Different Tablet Formulations Of Bosutinib

NCT00934674·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18–50

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Men or women of non-childbearing potential, age 18 to 50 years.

You may not be if

Any significant cardiovascular, renal, hepatic, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.

The record

StatusCompleted

PhasePhase 1

Taking part30

StartedJul 2009

UpdatedSep 2, 2009

Conditions

Where1

Tacoma, Washington, United States

Clareo Health | Study Comparing Two Different Tablet Formulations Of Bosutinib